Technology offers
These are the current technology offers. If you are interested in acquiring one of these technologies please contact us.
Therapy
- Complement Anaphylatoxin Binding Peptide for treating Ocular Fibrosis | Ref. No.: CH895
- Novel iron-oxide based Nanoparticles for Treating Hyperphosphatemia | Ref. No.: CH557
- Anti-TNFa and anti-IFNy for prevention or treatment of delayed bone fracture healing | Ref. No.: CH592
- Cytokine-Loaded Microparticles in Hyaluronic Acid for Treatment of Osteoarthritis | Ref. No.: CH519
- Immunmodulatory compounds for preventing delayed healing in patients with a musculoskeletal injury | Ref. No.: CH833
Diagnostic
- MACC1: Causal prognostic and predictive marker for cancer metastasis and recurrence risk stratification | Ref. No.: CH823 / CH100
- Novel Iron-(III)-tCDTA-based contrast agents for MRI and methods for producing them | Ref. No.: CH879
- Manual ELISA based on hnRNP-A3 Peptides for Diagnosis of Rheumatoid Arthritis | Ref. No.: CH370 / CH787
- Rapid and Specific Detection of most common Fungal Nail and Skin Infections | Ref. No.: CH859
- CD8 T-cell subsets as biomarkers for predicting non-fusion after spinal bone fusion surgery | Ref. No.: CH820
![[Translate to englisch:]](/fileadmin/_processed_/7/4/csm_Claudia_Keil-Dieckmann_4422_II_e27c9e4e9e.jpg)